Abstract
In this review we shall attempt to summarize the literature published on the high responders/low responders animal model of drug addiction. This model is based on the locomotor activity of rats in the mild stress of a novel environment. Rats that exhibit high rates of exploratory behaviours are deemed high responders (HR) and rats that exhibit low exploratory behaviours are deemed low responders (LR). Interestingly, the rate of these exploratory behaviours predicts the response of these animals to drugs of abuse. In this manuscript we will review the behavioural and physiological differences between HR and LR rats in response to d-amphemtamine, cocaine, morphine, alcohol and nicotine.
Keywords: behavioural sensitization, d-amphetamine, Conditioned Place Preference (CPP), Acute Locomotor Response, Morphine, Drug Abuse
CNS & Neurological Disorders - Drug Targets
Title: Individual Differences in Vulnerability to Drug Abuse: The High Responders/Low Responders Model
Volume: 5 Issue: 5
Author(s): Mohamed Kabbaj
Affiliation:
Keywords: behavioural sensitization, d-amphetamine, Conditioned Place Preference (CPP), Acute Locomotor Response, Morphine, Drug Abuse
Abstract: In this review we shall attempt to summarize the literature published on the high responders/low responders animal model of drug addiction. This model is based on the locomotor activity of rats in the mild stress of a novel environment. Rats that exhibit high rates of exploratory behaviours are deemed high responders (HR) and rats that exhibit low exploratory behaviours are deemed low responders (LR). Interestingly, the rate of these exploratory behaviours predicts the response of these animals to drugs of abuse. In this manuscript we will review the behavioural and physiological differences between HR and LR rats in response to d-amphemtamine, cocaine, morphine, alcohol and nicotine.
Export Options
About this article
Cite this article as:
Kabbaj Mohamed, Individual Differences in Vulnerability to Drug Abuse: The High Responders/Low Responders Model, CNS & Neurological Disorders - Drug Targets 2006; 5 (5) . https://dx.doi.org/10.2174/187152706778559318
DOI https://dx.doi.org/10.2174/187152706778559318 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sequential Comorbidity of Anxiety and Depression in Youth: Present Knowledge and Future Directions
Current Psychiatry Reviews Substance P in Rheumatic Diseases
Current Rheumatology Reviews Bacterial Toxins: A Hope Towards Angiogenic Ailments
Current Drug Metabolism Sensory-Motor Integration in the Medial Medulla
Current Neuropharmacology Binding Sites of Amyloid β-Peptide in Cell Plasma Membrane and Implications for Alzheimers Disease
Current Protein & Peptide Science Bioanalytical and Biophysical Techniques for the Elucidation of the Mode of Action of Metal-Based Drugs
Current Topics in Medicinal Chemistry Mitochondrial Dysfunction during Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Analysis of the Salivary Microbiome in the Periodontal Disease Patients with Hypertension and Non-hypertension
Current Bioinformatics Review of Structures Containing Fullerene-C60 for Delivery of Antibacterial Agents. Multitasking model for Computational Assessment of Safety Profiles
Current Bioinformatics Calcium Channel Blocker Ameliorates Nicotine Withdrawal Symptoms in Mice
Current Psychopharmacology Lysophospholipase D/Autotaxin in Lysophospholipid Biology
Current Enzyme Inhibition Docosahexaenoic Acid-Phosphatidylcholine Improves Cognitive Deficits in an Aβ<sub>23-35</sub>-Induced Alzheimer’s Disease Rat Model
Current Topics in Medicinal Chemistry A Molecular Bridge: Connecting Type 2 Diabetes and Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets CAM Use in Pediatric Oncology
Current Pediatric Reviews Global Expression Studies of Schizophrenic Brain: A Meta-Analysis Study Linking Neurological Immune System with Psychological Disorders
CNS & Neurological Disorders - Drug Targets Multiple Protective Functions of Sigma1 Receptor
Current Protein & Peptide Science Chalcone Derivatives Activate and Desensitize the Transient Receptor Potential Ankyrin 1 Cation Channel, Subfamily A, Member 1 TRPA1 Ion Channel: Structure-Activity Relationships in vitro and Anti-Nociceptive and Anti-inflammatory Activity in vivo
CNS & Neurological Disorders - Drug Targets Differential Effects of the Interaction Between the Education and APOE ε4 Allele on Amyloid-beta Retention and Memory Performances in Cognitively Normal Older Adults and Alzheimer's Disease Patients
Current Alzheimer Research MicroRNA-Targeted Signaling Pathways in the Autism Spectrum Disorder: Implications for Early Detection and Targeted Therapy
CNS & Neurological Disorders - Drug Targets PET and SPECT Exploration of Central Monoaminergic Transporters for the Development of New Drugs and Treatments in Brain Disorders
Current Pharmaceutical Design